BIOMAT Database Logo BIOMAT Database Logo

Use of the BACTEC system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complex. 1985

J E Steadham, and S K Stall, and J L Simmank

A total of 199 Mycobacterium tuberculosis, 182 M. kansasii, and 32 M. avium complex isolates were tested for susceptibility to either three or 10 color-coded drugs in a four-phase study using the conventional 7H10 plate method and the BACTEC system. Agreement between the two test systems for M. tuberculosis isolates against isoniazid, ethambutol, and rifampin was 96%; it was 93.6% against all 10 drugs. Disagreement was highest for ethionamide and cycloserine. M. kansasii data were encouraging, with 88.9% drug agreement against 10 drugs, but M. avium complex agreement was only 51.6% against 10. Average time required for reportable results was 4.8 days for M. tuberculosis, 4.3 days for M. kansasii, and 3.4 days for M. avium complex. Growth for 3 days in an enrichment medium yielded suspensions of the organisms in a logarithmic growth phase and reduced problems of clumps of cells in inocula.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009161 Mycobacterium A genus of gram-positive, aerobic bacteria. Most species are free-living in soil and water, but the major habitat for some is the diseased tissue of warm-blooded hosts. Mycobacteria
D009162 Mycobacterium avium A bacterium causing tuberculosis in domestic fowl and other birds. In pigs, it may cause localized and sometimes disseminated disease. The organism occurs occasionally in sheep and cattle. It should be distinguished from the M. avium complex, which infects primarily humans.
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D009170 Nontuberculous Mycobacteria So-called atypical species of the genus MYCOBACTERIUM that do not cause tuberculosis. They are also called tuberculoid bacilli, i.e.: M. abscessus, M. buruli, M. chelonae, M. duvalii, M. flavescens, M. fortuitum, M. gilvum, M. gordonae, M. intracellulare (see MYCOBACTERIUM AVIUM COMPLEX;), M. kansasii, M. marinum, M. obuense, M. scrofulaceum, M. szulgai, M. terrae, M. ulcerans, M. xenopi. Atypical Mycobacteria,Mycobacteria, Atypical,Mycobacterium duvalii,Mycobacterium flavescens,Mycobacterium gilvum,Mycobacterium gordonae,Mycobacterium obuense,Mycobacterium szulgai,Mycobacterium terrae,Mycolicibacter terrae,Mycolicibacterium duvalii,Mycolicibacterium flavescens,Mycolicibacterium gilvum,Mycolicibacterium obuense,Tuberculoid Bacillus,Atypical Mycobacterium,Mycobacterium, Atypical,Non-Tuberculous Mycobacteria,Nontuberculous Mycobacterium
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture

Related Publications

J E Steadham, and S K Stall, and J L Simmank
Nonweekend schedule for BACTEC drug susceptibility testing of Mycobacterium tuberculosis.
May 1986, Journal of clinical microbiology,
J E Steadham, and S K Stall, and J L Simmank
Use of Gen-Probe AccuProbes to identify Mycobacterium avium complex, Mycobacterium tuberculosis complex, Mycobacterium kansasii, and Mycobacterium gordonae directly from BACTEC TB broth cultures.
December 1994, Journal of clinical microbiology,
J E Steadham, and S K Stall, and J L Simmank
Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex.
November 2009, Journal of clinical microbiology,
J E Steadham, and S K Stall, and J L Simmank
[Utility of the direct culture examination (Ziehl-Neelsen) using the Bactec system for the presumptive identification of Mycobacterium tuberculosis complex, Mycobacterium avium complex, Mycobacterium xenopi, and Mycobacterium kansasii].
May 1994, Enfermedades infecciosas y microbiologia clinica,
J E Steadham, and S K Stall, and J L Simmank
Validation of bedaquiline drug-susceptibility testing by BACTEC MGIT 960 system for Mycobacterium tuberculosis.
January 2019, International journal of mycobacteriology,
J E Steadham, and S K Stall, and J L Simmank
Improved detection times for Mycobacterium avium complex and Mycobacterium tuberculosis with the BACTEC radiometric system.
November 1985, Journal of clinical microbiology,
J E Steadham, and S K Stall, and J L Simmank
Use of potassium tellurite for rapid-drug susceptibility testing of Mycobacterium avium complex.
May 2001, Journal of investigative medicine : the official publication of the American Federation for Clinical Research,
J E Steadham, and S K Stall, and J L Simmank
[Clinical features of pulmonary Mycobacterium kansasii infection: comparison with M. tuberculosis and M. avium complex infection].
December 1993, Nihon Kyobu Shikkan Gakkai zasshi,
J E Steadham, and S K Stall, and J L Simmank
Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 System.
May 2016, Journal of clinical microbiology,
J E Steadham, and S K Stall, and J L Simmank
Drug susceptibility testing of Mycobacterium leprae in the BACTEC 460 system.
December 1989, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!